Home › Funds › Citigroup Inc › DMAC
Citigroup Inc position in DMAC
DIAMEDICA THERAPEUTICS INC · Health Care
Latest position (Q2 2026)17.27K sh
Reported value held$121.59K
Portfolio Weight0.00%
First reportedQ1 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 273 | $1.00K | New |
| Q3 2024 | 22.10K | $92.59K | New |
| Q4 2024 | 38.47K | $208.91K | Add |
| Q1 2025 | 16.77K | $63.54K | Reduce |
| Q2 2025 | 9.38K | $36.58K | Reduce |
| Q3 2025 | 1.44K | $9.91K | Reduce |
| Q4 2025 | 864 | $6.88K | Reduce |
| Q1 2026 | 1.90K | $12.84K | Add |
| Q2 2026 | 17.27K | $121.59K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DMAC
- BlackRock Inc 2.25M sh · $15.86M · Q2 2026
- Geode Capital Management 894.12K sh · $6.30M · Q2 2026
- Millennium Management 845.31K sh · $5.95M · Q2 2026
- Vanguard Group 723.12K sh · $5.76M · Q4 2025
- Northern Trust Corp 327.52K sh · $2.31M · Q2 2026
- Goldman Sachs Group 168.07K sh · $1.18M · Q2 2026
- Citadel Advisors 145.87K sh · $1.03M · Q2 2026
- BNY Mellon 117.82K sh · $829.45K · Q2 2026
- Charles Schwab Investment Management 96.69K sh · $680.71K · Q2 2026
- Bank of America Corp 57.71K sh · $406.29K · Q2 2026
- Morgan Stanley 46.87K sh · $329.99K · Q2 2026
- Wells Fargo & Co 36.93K sh · $259.97K · Q2 2026